Table of Contents
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Tissue Regenerative Materials Overview 6
3 Products under Development 7
3.1 Tissue Regenerative Materials – Pipeline Products by Stage of Development 7
3.2 Tissue Regenerative Materials – Pipeline Products by Territory 8
3.3 Tissue Regenerative Materials – Pipeline Products by Regulatory Path 9
3.4 Tissue Regenerative Materials – Pipeline Products by Estimated Approval Date 10
4 Tissue Regenerative Materials – Pipeline Products under Development by Companies 11
4.1 Tissue Regenerative Materials Companies – Pipeline Products by Stage of Development 11
4.2 Tissue Regenerative Materials – Pipeline Products by Stage of Development 12
5 Tissue Regenerative Materials Companies and Product Overview 13
5.1 Biora AB Company Overview 13
5.1.1 Biora AB Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Collagen Matrix Inc Company Overview 14
5.2.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.3 Colorado Therapeutics, LLC Company Overview 16
5.3.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 credentis AG Company Overview 17
5.4.1 credentis AG Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 Gene Techno Science Co Ltd Company Overview 18
5.5.1 Gene Techno Science Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
6 Tissue Regenerative Materials- Recent Developments 31
6.1 Oct 22, 2019: CollPlant CEO Yehiel Tal appointed to serve on international society for Biofabrication’s Industry Relations Committee 31
6.2 Sep 26, 2019: CollPlant reports second quarter 2019 financial results and provides business update 31
6.3 Aug 29, 2019: Straumann Group announces two appointments to its Executive Management team 33
6.4 Aug 14, 2019: Straumann Group: Strong momentum continues as first-half organic revenue climbs 16% and core EBIT margin reaches 28% 34
6.5 Jun 20, 2019: Collplant announces corporate name change to Collplant Biotechnologies to better reflect its business 40
6.6 Jun 19, 2019: CelGro accelerates dental implant treatment 40
6.7 May 30, 2019: CollPlant reports first quarter 2019 financial results and provides business update 42
6.8 May 23, 2019: Full availability of Geistlich Fibro-Gide, the alternative soft-tissue graft 44
6.9 May 23, 2019: Credentis and DentaQuest Partner to Bring Innovative Cavity Prevention Products to US Markets 45
6.10 May 22, 2019: CollPlant Launches New HQ and R&D Center in Israel 46
6.11 May 16, 2019: CURODONT REPAIR is the superior treatment for white spots 46
6.12 May 01, 2019: Orthocell submits AUS regulatory application for CelGro 46
6.13 Apr 30, 2019: Promising start to the year with 17% organic growth in first quarter 47
6.14 Apr 11, 2019: CURODONT REPAIR FLUORIDE PLUS – distribution starts in the US 49
6.15 Apr 01, 2019: CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update 50
6.16 Feb 20, 2019: CURODONT PROTECT – Best Prophylaxis during Orthodontic Treatment 52
6.17 Feb 19, 2019: Straumann posts strong Q4, lifting full-year organic revenue growth to 19% as underlying EBITDA margin reaches 30% 52
6.18 Feb 04, 2019: CollPlant names Jonathan M.N. Rigby as Chairman of the Board 57
6.19 Jan 22, 2019: Straumann Group appoints Alastair Robertson as Head of Global People Management & Development 58
7 Appendix 59
7.1 Methodology 59
7.2 About GlobalData 62
7.3 Contact Us 62
7.4 Disclaimer 62
Table 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development 7
Table 2: Tissue Regenerative Materials - Pipeline Products by Territory 8
Table 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path 9
Table 4: Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date 10
Table 5: Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development 11
Table 6: Tissue Regenerative Materials - Pipeline Products by Stage of Development 12
Table 7: Biora AB Pipeline Products & Ongoing Clinical Trials Overview 13
Table 8: Straumann Emdogain FL - Product Status 13
Table 9: Straumann Emdogain FL - Product Description 13
Table 10: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 11: MatrixMem - Product Status 14
Table 12: MatrixMem - Product Description 14
Table 13: Socket Repair Kit - Product Status 15
Table 14: Socket Repair Kit - Product Description 15
Table 15: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 16
Table 16: Xenograft Implant - Dental - Product Status 16
Table 17: Xenograft Implant - Dental - Product Description 16
Table 18: credentis AG Pipeline Products & Ongoing Clinical Trials Overview 17
Table 19: CUROLOX Perio - Product Status 17
Table 20: CUROLOX Perio - Product Description 17
Table 21: Gene Techno Science Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
Table 22: GCT-101 - Product Status 18
Table 23: GCT-101 - Product Description 18
Table 24: Histocell SL Pipeline Products & Ongoing Clinical Trials Overview 19
Table 25: Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Status 19
Table 26: Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Description 19
Table 27: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 20
Table 28: Electrospun Scaffold - Product Status 20
Table 29: Electrospun Scaffold - Product Description 20
Table 30: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 31: MaxiGuide - Product Status 21
Table 32: MaxiGuide - Product Description 21
Table 33: Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview 22
Table 34: Bone Inductive Implant - Product Status 22
Table 35: Bone Inductive Implant - Product Description 22
Table 36: Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview 23
Table 37: OrthoNovaOss - Product Status 23
Table 38: OrthoNovaOss - Product Description 23
Table 39: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
Table 40: CelGro - Dental - Product Status 24
Table 41: CelGro - Dental - Product Description 24
Table 42: Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 25
Table 43: Inorganic Dental Cement - Product Status 25
Table 44: Inorganic Dental Cement - Product Description 26
Table 45: Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 27
Table 46: Soft Tissue Control Implant - Product Status 27
Table 47: Soft Tissue Control Implant - Product Description 27
Table 48: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
Table 49: DentaColl - Product Status 28
Table 50: DentaColl - Product Description 28
Table 51: SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 52: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Status 29
Table 53: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Description 29
Table 54: Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview 30
Table 55: Tigran Porous Titanium Granules - Alveolar Fillings - Product Status 30
Table 56: Tigran Porous Titanium Granules - Alveolar Fillings - Product Description 30
Table 57: Glossary 61
List of Figures
Figure 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development 7
Figure 2: Tissue Regenerative Materials - Pipeline Products by Territory 8
Figure 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path 9
Figure 4: Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date 10
【免責事項】
https://www.marketreport.jp/reports-disclaimer